Publications by authors named "Richard Malamut"

21Publications

Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study.

J Pain 2016 11 20;17(11):1198-1206. Epub 2016 Aug 20.

Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York; Department of Neurology, and Psychiatry, and Center for Human Experimental Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpain.2016.07.008DOI Listing
November 2016

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.

Pain 2016 Sep;157(9):1836-50

aCentre for Medical Education, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom bDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA cDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA dDepartment of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA eDepartment of Occupational Science and Occupational Therapy, University of Toronto, ON, Canada fInstitute for Work and Health, University of Toronto, ON, Canada gDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA hInstitute for Work and Health, University of Toronto, ON, Canada iDepartment of Neurology, University of Rochester, Rochester, NY, USA jDepomed, Newark, CA, USA kLORAGroup LLC, Royal Oak, MD, USA lDepartment of Health Services Research University of Maryland, Baltimore, MD, USA mPublic Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA nDivision of Infection and Immunity, Cardiff University, Cardiff, Wales, United Kingdom oNIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom pInstitute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom qAmerican Chronic Pain Association, Rocklin, CA, USA rDepartment of Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA sDepartment of Neurology, Harvard University, Cambridge, MA, USA tDepartment of Anesthesiology, Queen's University, Ottawa, ON, Canada uDepartment of Psychiatry, Duke University Medical Center, Durham, NC, USA vPfizer, Inc, Durham, NC, USA wClinical and Rehabilitative Medicine Research Program, United States Army Medical Research and Materiel Command xPurdue Pharma L.P., Stamford, CT, USA yDepartment of Veterans Affairs, Veteran Affairs Connecticut Healthcare System, West Haven, CT, USA zDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA aa

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/pain/2016/09000/Assessment_of_p
Web Search
http://dx.doi.org/10.1097/j.pain.0000000000000577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453823PMC
September 2016

Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.

Pain Manag 2016 Oct 6;6(5):497-508. Epub 2016 Apr 6.

TEVA Pharmaceuticals, Frazer, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pmt-2015-0005DOI Listing
October 2016

Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.

Postgrad Med 2016 Jan 18;128(1):85-96. Epub 2015 Dec 18.

a TEVA Pharmaceuticals , Frazer , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00325481.2016.1120642DOI Listing
January 2016

Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.

J Opioid Manag 2015 Sep-Oct;11(5):425-34

Vice President, Global Clinical Development, Pain Therapeutic Area Head, Teva Pharmaceuticals, Frazer, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5055/jom.2015.0292DOI Listing
February 2016

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Pain 2015 Jul;156(7):1184-97

aDepartment of Anesthesiology, University of Rochester, Rochester, NY, USA bUniversity of Washington, Seattle, WA, USA cUniversity of Pennsylvania, Philadelphia, PA, USA dUniversity of Florida, Gainesville, FL, USA eQueen's University, Kingston, ON, Canada fHarvard University, Boston, MS, USA gJohns Hopkins University, Baltimore, MD, USA hGerman Diabetes Center at Heinrich Heine University, Düsseldorf, Germany iLora Group, LLC, Royal Oak, MD, USA jAmerican Chronic Pain Association, Rocklin, CA, USA kPfizer and Duke University, Raleigh-Duram, NC, USA lGlaxoSmithKline, London, United Kingdom mEli Lilly, Indianapolis, IN, USA nVirtuous Pharma, Inc, Raleigh-Durham, NC, USA oYork University, Toronto, ON, Canada pRigshospitalet, Copenhagen University, Denmark qEndo Pharmaceuticals, Inc, Malvern, PA, USA rTeva Pharmaceuticals, North Wales, PA, USA sAcelRx, Redwood City, CA, USA tArlington, VA, USA uJohnson and Johnson, Titusville, NJ, USA vGrünenthal GMbH, Aachen, Germany wJazz Pharmaceuticals, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000000191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769693PMC
July 2015

The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.

Clin Auton Res 2012 Apr 2;22(2):79-90. Epub 2011 Nov 2.

Department of Neurology, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10286-011-0146-2
Publisher Site
http://dx.doi.org/10.1007/s10286-011-0146-2DOI Listing
April 2012

Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome: an evidence-based review.

Muscle Nerve 2005 Aug;32(2):236-40

American Association of Neuromuscular & Electrodiagnostic Medicine, 421 First Avenue SW, Suite 300E, Rochester, Minnesota 55902, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.20393DOI Listing
August 2005

Diabetic retinopathy: treating systemic conditions aggressively can save sight.

Cleve Clin J Med 2005 May;72(5):447-54

Division of Ophthalmology, Crozer-Chester Medical Center, Upland, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.72.5.447DOI Listing
May 2005